The University of Chicago Header Logo


Samuel Hellman to Receptors, Tumor Necrosis Factor, Type I

This is a "connection" page, showing publications Samuel Hellman has written about Receptors, Tumor Necrosis Factor, Type I.
  1. Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. Cancer Gene Ther. 2009 Apr; 16(4):373-81.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.